‘Milestone’ Study Zeros in on 5-Year Safety Data From Upadacitinib TrialsDecember 26, 2023PediatricsDermatology
How to Reduce Cardiovascular Morbidity and Mortality in Psoriasis and PsADecember 19, 2023Preventive CareDermatologyRheumatology
Roflumilast foam gets nod as new option for seborrheic dermatitisDecember 18, 2023Mixed TopicsDermatologyPediatrics
Pilot study educates barbers about pseudofolliculitis barbaeDecember 15, 2023Diversity in MedicineDermatology
GVHD raises vitiligo risk in transplant recipientsDecember 15, 2023Mixed TopicsDermatologyOncologyHematology
FDA mandates five changes to iPLEDGE program for isotretinoinDecember 6, 2023DermatologyPediatricsContraceptionMixed Topics
Analysis supports link between psoriasis and obstructive sleep apneaDecember 5, 2023Sleep MedicineDermatology
Isotretinoin users do not have higher suicide risk: meta-analysisNovember 30, 2023Mixed TopicsDermatologyMental HealthPediatrics
FDA warns of potentially lethal reaction to seizure medsNovember 29, 2023NeurologyDermatologyImmunologyMixed Topics
At 52 weeks, complete hair regrowth rates still climbing on deuruxolitinibNovember 27, 2023Dermatology
Tapinarof effective for AD in patients as young as 2 yearsNovember 27, 2023PediatricsDermatologyImmunology
Diagnosing patients with sarcoidosisNovember 17, 2023Rare DiseasesPulmonologyHepatologyDermatologyImmunology
